The FDA’s late 2025 approval of hydrogen peroxide as a direct meals additive for a number of makes use of, together with as an antimicrobial and bleaching agent is a watershed regulatory second for us. We are actually engaged with important companions, together with Danone and Nestle and are actively successful bids, each immediately and thru service suppliers. SteraMist iHP is demonstrating real-world efficacy throughout a variety of meals processing environments. We’re actively pursuing a meals contract notification or FCN and have recognized 2 particular alternatives to boost our efforts on a tailor-made FCN for powdered toddler system, which comes on the request of an present buyer.
Moreover, we’re awaiting approval of our -4 label from the EPA for our hashish trade and different requested markets in our Meals Security division. We additionally plan to submit a -5 EPA label based mostly on the research carried out with Plum Island as beforehand introduced. A landmark USDA research confirmed BITs efficacy towards the shaped wing virus for agricultural biosecurity in honeybees. In 2025, SteraMist was honored with the Disinfection Decontamination Merchandise Firm of the Yr Award by MedTech Outlook. We achieved compliance, recognition throughout 3 security vendor administration platforms and are within the strategy of including a fourth to assist 2 ongoing integration initiatives at a well known Baltimore hospital.
Our customer support crew is actively transitioning our bigger base to open order insurance policies for assist service choices and BIT Answer orders. The backlog of our orders for assist companies is up 16%, and BIT Answer is up 24% within the first quarter of 2026 in comparison with the identical interval final yr, offering early and compelling indicators of accelerating recurring income trajectory we’re constructing. To our long-term supporters of our know-how and firm, we’re happy to announce that we’re lastly receiving approvals from the HSE and the BPR submissions, we are actually formally acknowledged in the UK, together with Wales and Northern Eire in addition to within the Netherlands.
The current approval within the Netherlands strengthens our confidence that different EU nations will quickly comply with swimsuit. Our coronary heart monitoring gadget venture is nearing completion and is scheduled for manufacturing facility testing subsequent month. We’re getting ready to introduce our iHP gadget to the U.S. markets by way of the suitable regulatory pathways, together with the FDA 510(ok) premarket notification course of as soon as testing is finalized. The success of receiving the FDA 510(ok) implies that we’ll lastly be capable to go after your entire ethylene oxide sterilization market. The worldwide ethylene oxide market was a $5.29 billion market final yr. Key progress components is a rising demand for sterilized medical consumables and improved healthcare infrastructure, notably for hospital, labs and surgical procedure facilities.
Our know-how is protected by greater than 30 utility and design patents by way of 2038, and is deployed in over 40 nations. We’re getting into 2026 with operational momentum, rising recurring income and increasing world buyer base and a transparent technique to drive sustainable progress. Our focus stays on execution, changing our pipeline into acknowledged income whereas persevering with to advance the know-how platform that makes all of this doable. The pipeline that we’ve is the strongest we have ever had. Our first quarter 2026 income is larger than our first quarter of 2025. I’ll talk about some particulars in my conclusion at present, however our complete alternative e book for integration initiatives stays at $16 million.
Your complete SteraMist iHP alternative e book is at present at $20 million. Nevertheless, first, I’ll now hand the decision over to our Chief Monetary Officer, David Vanston, who will present an outline of the monetary outcomes for the total yr ended December 31, 2025, in comparison with the identical interval in 2024. David?
David Vanston: Thanks, Dr. Shane. I’ll now stroll you thru our full yr ’25 monetary outcomes. Our full audited monetary statements are included within the Type 10-Ok we filed with the SEC and in at present’s press launch. Income for the yr ended December 31, 2025, was $5.6 million in comparison with $7.7 million in ’24. The decline was pushed primarily by the timing of buyer gear purchases. Service income remained comparatively steady year-over-year, which we view as an indicator of the sturdiness of our put in base. Gross margin improved to roughly 55%, up from 46% in ’24, reflecting decrease price of gross sales and a discount of stock reserves in comparison with the prior yr.
Complete working bills had been $6.9 million, down roughly 10% from ’24, reflecting disciplined price administration. The web loss was $3.7 million or $0.19 per share, an enchancment from a internet lack of $4.5 million or $0.22 per share in 2024. We ended the yr with roughly $88,000 in money. Working capital was roughly $1 million, and we used $1.2 million in working money throughout ’25, an enchancment from $1.4 million in ’24. We have now taken steps to handle our liquidity place, together with a $535,000 convertible word increase throughout ’25, a $20 million fairness line of credit score with Hudson International Ventures entered into November ’25, from which we’ve made our first draw roughly $94,000 in February ’26.
We have finished an efficient S3 shelf registration for as much as $50 million, and we have engaged Bancroft Capital to discover further financing choices. I encourage traders to evaluate our Type 10-Ok in full. I’ll now flip our name over to our Chief Working Officer, Shane to debate upcoming enterprise highlights.
Elissa Shane: Thanks, David. As Dr. Shane highlighted earlier within the name, we’re actively specializing in open BIT Answer orders and annual service choices, resulting in the next open gross sales e book metric. This initiative stems from our progress in personnel and operations, together with our enhanced complete coaching program that prioritizes steady recertification. This technique not solely elevates buyer requirements for implementation and security, but additionally has the potential to drive further income and foster deeper product adoption sooner or later.
The gross sales efficiency of assist companies and BIT Options gross sales are anticipated to exceed 2025 ranges as evidenced by the rise of 16% within the backlog of orders for TOMI Help Companies and a rise of 24% in BIT Answer backlog of orders for the primary quarter of 2026 in comparison with the identical interval final yr. Dr. Shane additionally supplied up to date data on 2025 bulletins for only a handful of shoppers.
This contains anticipated orders from our aquaculture buyer, a accomplished Customized Engineered System, or CES, for the Rhode Island College, 2 iHP chambers for the biopharmaceutical associate, a second order with our associate in Malaysia, and a 3rd location in Berlin, Germany for the attention well being firm, which we count on will proceed with the identical normal working procedures as the primary 2 websites. We anticipate roughly $3 million in gross sales amongst these 5 prospects and the developments in assist companies and BIT Options gross sales for 2026. It is vital to notice that this projected $3 million in income contains roughly $920,000 that overlaps with the $3 million integration pipeline introduced on November 26, 2025.
When factoring in our iHP deployment companies, which generates over $1 million constantly, we are able to confidently state $6 million in income simply amongst 5 prospects and three income streams for 2026. To this point, roughly $800,000 has been acknowledged from the November 2025 $3 million integration pipeline. This quantity originates from 10 distinct buyer orders. Of those 10, 7 prospects have formally positioned the order. We anticipate remaining approvals from the remaining 3 accounts, and we’ve added 4 extra integration initiatives transferring in direction of CapEx approvals for the reason that November announcement, which is anticipated to contribute one other $2.3 million to our energetic instant integration venture pipeline.
Our East Coast distributor, ARES Scientific, has been instrumental in securing a number of college wins for our SIS platform. We’re actively collaborating with VWR, Avantor, participating with all case managers and overhauling advertising initiatives with them. We’re prioritizing the continued schooling and engagement of our worldwide companions, investing in them to advertise their very own long-term buyer base as a substitute of increasing into new areas. This strategic focus, coupled with current regulatory approvals, is anticipated to assist our progress and positively affect our income.
For instance, we’ve efficiently obtained HSE approval and introduced a most well-liked partnership with Complete Clear Air, or TCA in the UK, the place we just lately accomplished manufacturing facility testing on a customized engineered venture that they dropped at us. TCA has additionally invested in cell gear in quarter 1, 2026 to assist their demonstration and repair deployment capabilities. The meals security sector can be starting to realize momentum, and we’re receiving invaluable referrals and case research from our present purchasers. This trade makes use of our SteraPak product or requires customized functions, indicating that we’re nonetheless within the early phases of realizing important income. Moreover, there stays a lot work to be finished on the regulatory entrance.
For instance, Nestle’s pending enlargement waits for different worldwide registrations outdoors those obtained within the European Union. Probably the most thrilling developments comes from our long-standing relationship with Disinfectant Care, which has secured a service contract at a significant dairy facility in Mexico. Following customer-specific testing and research carried out on website, SteraMist iHP not solely demonstrated its efficacy, but additionally confirmed the preservation of cheese high quality, a key discovering that strengthens our credibility and served as a invaluable referral for different new prospects. In abstract, we are actually making strides throughout a various vary of sectors within the meals trade.
We’re utilized in cheese, eggs, espresso, ice cream, client packaged items, hashish, diet, vertical farming, pet meals, meals ingredient suppliers, refrigerated meals and specialty ingredient suppliers. That is broadening of our market presence positions us effectively within the trade. One other important space of focus for us, which we imagine is anticipated to see returns in 2026 is the organic security cupboard or BSC trade, notably concerning our service suppliers and the SIS stand-alone system. We have now developed the required equipment and protocols for treating all courses of cupboards, a progress required as we put together for NSF approvals this summer time.
Presently, we’ve licensed service suppliers using our SteraMist iHP know-how, together with ( Triumvirate ) and MarathonLS on the East Coast in addition to HEPA in Canada. On April 2, we carried out a key demonstration with one of the crucial acknowledged suppliers within the trade who operates a number of areas throughout the USA. Triumvirate hosted a webinar this quarter the place they showcased how iHP know-how outperforms key opponents available in the market, together with Spor-Klenz, Formaldehyde, and Vaporized Hydrogen Peroxide. This webinar was effectively attended attracting roughly 250 contributors. Finally, our purpose is to allow these service suppliers to compete successfully by incorporating iHP know-how into their choices for BSCs.
They admire this innovation as a result of it permits them to finish extra therapies in a single day in comparison with older applied sciences. As well as, we preserve a strong mental property portfolio, CE and UL listings and are getting ready to pursue USP 1072 materials efficacy, which is able to expedite our gross sales course of within the life sciences market. Moreover, we’re dedicated and continued to conduct customer-specific research that assist us safe contracts and preserve the consumer roster we maintain, comparable to these highlighted at present. I’ll now return the decision again to our CEO, Dr. Halden Shane.
Halden Shane: Thanks, EJ. I need to take a second, perhaps much more of a second and specific deep appreciation to nearly all of our shareholders who supported us and have believed in our mission by way of our highs and lows. You’re the majority and our long-term traders. Thanks for supporting our crew and most significantly, believing in our know-how and merchandise. I imagine at first, all of us knew this was not going to be simple as a result of we’re creating a brand new normal in lots of industries, and it’s extremely onerous to perform being undercapitalized makes it even more durable. However we’re on the verge of engaging in the inconceivable.
To the handful of naysayers, we imagine we’ll be capable to earn your assist, and we proceed to execute a deliberate technique to broaden our operations and enhance our monetary efficiency. If not, then perhaps it is the improper firm or you should see an expert. It was a troublesome yr for us from the monetary perspective, however we stay targeted the entire time on the long run. In my eyes, there aren’t any excuses, however had been undoubtedly roadblocks. These roadblocks included DOGE, tariffs, working capital and just lately the conflict. We selected to turn into the usual within the pharmaceutical, life science and college vivarium market.
Sadly, among the negatives of changing into a normal in that market is the right storm that occurred in 2025. Like there was panic shopping for behind the 2020 COVID, there was an absence of shopping for within the 2025 as a result of causes I acknowledged above. Only recently obtained an e-mail from a significant college that everyone is aware of on the West Coast of the USA. They had been laying aside a purchase order till the top of 2026. The explanation they needed to postpone the acquisition was due to DOGE, tariffs and political uncertainty, together with the conflict. Additionally, that individual acknowledged there was an uncertainty perhaps about her job.
However regardless of, we’re a crew, and we are able to overcome conditions like that. And I can guarantee it is all short-term. The college will buy this yr even when it is a new skilled in that job place. I did a evaluate of our inventory during the last 10 years. I select sure factors as a result of it was roughly once we obtained our hospital well being care EPA registration and had advertising in place. The important thing metrics are fairly superb. In 2014, income was about $2.2 million. Our inventory worth was $2.16. Our main purchasers was a Panamanian hospital and a bunch in Mexico attempting to promote to Mexican hospitals. In 2020, we had a banner yr.
Sadly, it was as a result of pandemic. We did $25 million, demonstrated that we’re able to dealing with that quantity of enterprise. It did take away from the concentrate on the life science trade, prescribed drugs, et cetera, however most of that was short-term panic shopping for. Our inventory worth was $4.57. In 2024, our income was roughly $7.7 million. Our consumer checklist was fairly spectacular in comparison with 2014, and our inventory worth ended up at $1.05. The subsequent yr, 2025, our gross sales was $5.6 million. The gross sales that we may acknowledge as income, clearly, as , the gross sales had been a lot greater, as we acknowledged, supplied in our pipeline with open important orders for the primary time transferring throughout into 2026.
As acknowledged beforehand, we had been confronted with tariffs, DOGE, political uncertainty. We closed the yr with a inventory worth of $0.78. Now we’re in 2026. It seems like our first quarter, which incorporates acknowledged income and open orders, could possibly be $3 million or greater. Undecided how this finally ends up taking part in out later at present. However for certain, we’re beating our first quarter 2025 income within the first quarter of 2026. Our inventory worth is round $0.55. We estimate our income for this yr will probably be round $12 million, bearing any unknowns. In 2020, we did a reverse break up. Right this moment, that $0.55 comes out to be about $0.0688 pre-split. So this is a brief checklist of our present purchasers.
Pfizer, Merck, Thermo Fisher, Fresenius Kabi, ( Allogene ), Boehringer Ingelheim, Catalent, CSL, ( Seqirus ), ITH Prescribed drugs, Nestle Purina, Mead Johnson, ( Ziegler ), Simplot, Perdue AgriBusiness, Kindred Well being, Mercy Well being, Novant Well being, St. Jude Kids, Gila River Well being Care, FDA, USDA, CDC, NIH, DHS, USAMRIID, ( Armitron ), ESCO, ( Telestar ), ServiceMaster, First Onsite, Avantor, Tecumseh. Looking back, do you suppose an organization like TOMI with that checklist is value $0.0688 solely? My level right here is our inventory worth was $2.14 once we had 2 prospects, 1 in Panama and 1 in Mexico.
I keep in mind an announcement from a really profitable individual, Warren Buffett, “be grasping when others are fearful.” That assertion could not be true at present about our firm. I select to run this firm making a call that many CEOs won’t ever make. And that is as a result of it hurts earlier than it pays. I cease counting on simple gross sales and onetime gear and construct one thing from a stronger recurring management over how prospects function. The shift doesn’t present up cleanly on quarterly charts. It exhibits up as a service income climbs and consumables substitute capital purchases. Our prospects cease shopping for, they begin attending. That’s the place the sport adjustments. We aren’t rising very quick, however we’re rising very good.
Our firm has moved from episodic income to embedded income earlier than a deal closes, the connection reset. Not each deployment creates a tail, extra utilization, extra substitute, extra service. This isn’t a product enterprise anymore. It is a system. Recurring income is not about stability. It is about management. Most executives say they need predictable income. What they really need is predictable income with out sacrifice. We took the hit upfront. Volatility elevated, income appeared uneven. Margins needed to be rebuilt. However beneath the engine modified. Quick-term coverage facility is commonly the worth of long-term dominance. As a substitute of constructing costly infrastructure scale globally, we use distribution channels and partnerships to broaden and attain with out increasing prices.
Worldwide income turned a big slice of the pie with out dragging down the stability sheet. That is not enlargement. That is leverage we used. Scale with out price is the cleanest type of progress. On the identical time, we needed the enterprise in direction of higher-margin options and repair — companies. That is our razor-razor blade mannequin, not louder, not final yr, simply higher economics. The next present numbers may presumably change, however the level I need to make is that at this second, our economics, after all, is first based mostly on gross sales of apparatus income, however our scaling and cleanest type of progress is answer gross sales, assist service and iHP in-house service. Quarter 1 of 2025, we did $299,000 change in answer gross sales.
In quarter 1 of 2026, at this second, our answer gross sales are $429,413. So far as assist companies in quarter 1 of 2025, we had 73,279. Presently, within the first quarter of 2026, we’ve 253,390. In assist companies, these are things like coaching, certifications, {qualifications}, validation cycle developments, installations, et cetera. And the third half, iHP service. Within the first quarter of 2025, we had $439,386. Presently, with bill and open orders, we’ve a complete of $729,440. Margins improved, combine improved, the enterprise turned extra resilient with out saying it. We had been ready to determine learn how to obtain success by having cash truly compound. Do you retain chasing income to reset each quarter?
Or do you endure short-term ache to construct income that compounds with out permission. That call defines whether or not you are taking part in offense or taking part in survival. We did not get rid of threat. We repositioned it. In doing so, we created one thing extra invaluable than progress. We created dependency in a world chasing pace. We selected construction and construction wins. I am unable to take the credit score for all this writing. I need to thank ( Joel Block ) for understanding how we’ve created this firm and understanding the struggling we have gone by way of. As soon as once more, I need to thank everybody for his or her long-term dedication and assist and for a small crew of 20 working endlessly to realize all of the objectives.
I additionally need to thank our collectors who’ve been tremendous as we undergo the stage of progress. On the finish, the soldiers which have helped us obtain success. Additionally, I would like all people to hope for our courageous troopers which can be in tough state of affairs. To all which can be listening, we’re enthusiastic about what’s forward. Operator, let’s open the decision to questions.
Operator: (Operator Directions) And the primary query at present will probably be from ( Carl Wright from Lonetown Capital ).
Unknown Analyst: So first query, may you present some extra perception into the worldwide alternatives you talked about within the quarter?
Elissa Shane: Sure. Hello, Carl. Definitely. So the primary of the EU registrations on the submission we did got here in, so we count on many different EU states to comply with swimsuit inside the subsequent upcoming months. And with that, we’ve been positioned with present relationships and distributors from Poland, Germany, Netherlands which have been round our know-how and actually educated to have the ability to tackle the alternatives which have been ready for simply that registration. So simply because the U.Ok. did as soon as the HSE got here by way of earlier on this quarter with bringing on TCA and shortly having the ability to fulfill our first customized engineered system, I see that taking place with the opposite areas within the EU.
Unknown Analyst: Acquired it. After which congratulations on bringing down working bills by 10%. May you present a bit of extra colour about how we must always take into consideration working bills within the enterprise simply going ahead?
Halden Shane: Certain. David, go forward.
David Vanston: Certain. I believe the — once more, as Dr. Shane talked about earlier, as we develop, we should make investments into our working bills, however we have already got leverage in it. So we don’t count on to see a major bounce in our working bills. It is best to — if you are going to mannequin it, you’d mannequin it as a share of income progress. However I’d say it might barely lower as we develop as a share.
Operator: (Operator Directions) The subsequent query is coming from John Nelson. John is a personal investor.
Unknown Attendee: A number of questions. First one, I am a kind of long-term traders that…
Halden Shane: I do know you might be.
Unknown Attendee: Is — assured that through the years you are going to ship. So thanks. Thanks in your…
Halden Shane: And I thanks in your assist.
Unknown Attendee: First query is, you talked about within the press launch in ’25 versus ’24 revenues, prospects deferring, capital expenditure, initiatives on account of unsure financial surroundings with the impression of tariffs and Center East disaster. Are you seeing any indicators of — and also you should be seeing some indicators of it bettering due to your first quarter feedback. However are you seeing any of these prospects that had been deferring CapEx initiatives beginning to transfer on them?
Halden Shane: We’re.
Unknown Attendee: Okay. After which the BIT Answer revenues for ’25 versus ’24. Are you able to present any particulars on the comparisons there?
Halden Shane: Certain. Are you speaking ’24 versus ’25 or ’25 versus ’26?
Unknown Attendee: No, ’24 versus — ’25 versus ’24.
Halden Shane: Okay. EJ?
Elissa Shane: Sure. There’s a rise within the answer between ’24 and ’25, and we’re seeing that proceed into ’26. A variety of it has to go in with Dr. Shan’s closing and this moved into open orders. And this got here in tandem. About 1.5 years in the past, we talked about a giant push on completely different assist companies. And having us be capable to go on website and pace up using our know-how and qualify completely different areas, we’re in a position to predict how a lot answer they are going to have the ability to use. In order that, in essence, is now lastly beginning to repay with them buying the orders that they want prematurely and simply get into extra of an auto cargo.
So that is the purpose, and it is beginning to come into play. It began on the finish of 2025, and it is transferring into this yr as effectively. In order that’s the massive distinction. And the two, why it is referenced within the script that method is as a result of they go in hand. Our assist companies and our BIT Answer are undoubtedly collectively in developments.
Unknown Attendee: Okay. After which are most of your prospects in ’25 utilizing extra — considerably extra BIT Answer than they did the prior yr?
Elissa Shane: Sure, undoubtedly. I imply there’s at all times some fluidity to it since you’ll have our service supplier shift — if there’s — the fires produced plenty of answer in Q1, completely different decommissioning of buildings in the event that they get giant — giant service contracts, then this undoubtedly will increase our answer. In order that’s a bit of more durable to foretell. However once we’re in a position to go in and qualify completely different areas or just like the attention well being firm the place we all know how and precisely the place they’re utilizing the gear, that is a bit of simpler. However the Q1 of final yr actually was on account of some emergency use. So there’s undoubtedly a rise in answer.
Unknown Attendee: Okay. After which on — are you able to present any extra element so far as how the appliance can be used to cope with the wing syndrome for honeybees?
Elissa Shane: So we do — we’ve the research, and we have finished just a few different lab sort research, and it is undoubtedly a great use, and we’re trying and are nonetheless talking with an area college on attempting to get stay use case. As soon as we’re in a position to reestablish that and precise software use, it is going to proceed from there.
Halden Shane: So John, I’ve reached out to the associations, the honeybee associations, home, globally. I’ve reached out to the Board, and I’ve but to get a reply and with overwhelming proof of what we are able to do and the way we can assist the pollinators around the globe. And proper now I am reaching out to the Division of Agriculture to see in the event that they can assist or not less than get this know-how in entrance of someone that desires to make a change.
Unknown Attendee: Okay. And then you definately had talked about briefly the use for treating marijuana vegetation?
Halden Shane: Proper.
Unknown Attendee: Is it mites — or is it for the powdery mildew?
Halden Shane: It is for powdery mildew funguses on the vegetation. We have now an EPA label we’re attempting to get from the EPA only for that. Is that – 4, EJ?
Elissa Shane: Sure, that is appropriate.
Unknown Attendee: Okay. And — however at present, you are not getting any revenues but from that specific sort of utilization, appropriate, due to the necessity for the EPA label?
Halden Shane: I believe, EJ, you may reply that. I believe there have been some…
Elissa Shane: There is a handful of shoppers. With them, it is scaling up. And proper now, they’re doing plenty of handheld therapies, however we do have a great associate that’s selling our product and even some worldwide curiosity on the remedy. However we do have some broad use, which is nice, and that normally is step one.
Unknown Attendee: Okay. Good. After which one factor that I have been inquisitive about is and whether or not you have explored or considered exploring it’s makes use of of SteraMist within the navy. And I used to be fascinated about it on the subject of the Center East disaster with the entire Navy ships and the — within the Gulf and the way persons are crowded collectively. It is bought to be a possible respiration round for germs and potential infections switch. So has that — have you ever explored that in any respect or ever talked to the Navy about doable utilization of SteraMist?
Halden Shane: So the Navy has been — are they nonetheless a buyer, EJ?
Unknown Attendee: No. Properly, are they — if they’re a buyer, that is new to me, however have you ever explored makes use of with it? And when you’ve got, what response have you ever gotten from the navy?
Halden Shane: I believe we’re a bit of too small and overwhelmed with every thing to go after that in the intervening time. However I imagine there was a testing middle that the Navy was concerned with. It is an incredible concept and particularly with the brand new COVID variant that appears to be working round and got here from the Netherlands to the U.S., I am certain that you simply’re proper of the shut proximity on these ships, they do have to get a disinfectant. And I believe that is one thing that we will go look into instantly.
Elissa Shane: And we’ve accomplished some request for data on the grant authorities website for navy automobiles and learn how to finest implement SteraMist. So they’re creating data that method, however that does take fairly a little bit of time. However we do full these frequently to get the (indiscernible) on the market.
Unknown Attendee: Okay. And I do not know if there’s a specific certification required, however I used to be pondering the identical factor about SteraMist software potentialities for navy hospitals or the VA, which, as we all know, has quite a lot of issues with infectious illness transfers.
Halden Shane: I believe they’re ready for me to reply, John.
Elissa Shane: Sorry, I do not — not something particular. I believe ( nearly ) to that. We do have a closed service supplier been into navy housing, however too early to discuss.
Unknown Attendee: Okay. And my — one in every of my remaining questions was going to be on scale up. When you do get a major quantity of recent orders, how simple or tough that might be for you?
Halden Shane: Properly, it is — once more, we most likely want to boost some capital to scale up considerably. The 20 folks we’ve do a hell of a job as a crew. We had been in a position to deal with COVID just about with the identical quantity of workers, and we did very well. So I believe we may deal with the instant scale up relying upon the gear, however we undoubtedly have to go forward and improve the scale of the corporate going ahead in numerous divisions.
Unknown Attendee: Okay. Good. After which final query was quite a lot of — have you ever truly complete them up so far as the variety of new prospects added internet in ’25 versus ’24?
Halden Shane: I have never — David, EJ, have any of you finished that?
David Vanston: No.
Elissa Shane: Not based mostly on new prospects, no. Positively — particular person orders between the years, however…
Halden Shane: I believe we’ll try this, John, and I am going to discuss it on the decision arising quickly in 6 weeks.
Unknown Attendee: Okay. I imply you undoubtedly have listed quite a lot of new names that I hadn’t heard on earlier calls. So — however I used to be simply inquisitive about…
Halden Shane: Sure, I do know. And I not noted half of them, too, but it surely was inconceivable to undergo all of them. It is simply irritating to see what occurs to the inventory and what happens with the distinction. So the purpose, I believe, was effectively made, and we’ll see what goes on.
Unknown Attendee: Okay. After which as far — you have finished a wonderful job of including important distributors, each domestically and internationally. Do you — is that also a major a part of efforts going ahead so as to add much more distributors?
Halden Shane: Completely. We’re in talks proper now with many.
Operator: There aren’t any different questions right now. I’d now like to show the decision again to Dr. Halden Shane for closing remarks.
Halden Shane: Okay. I simply need to thank all people once more and need all people a contented Passover and joyful Easter. Thanks, operator.
Operator: Thanks. This does conclude at present’s convention. Chances are you’ll disconnect your strains right now, and have an exquisite day. Thanks in your participation.
Halden Shane: You too. Thanks.
Do you have to purchase inventory in Tomi Environmental Options proper now?
Before you purchase inventory in Tomi Environmental Options, take into account this:
The Motley Idiot Inventory Advisor analyst crew simply recognized what they imagine are the 10 best stocks for traders to purchase now… and Tomi Environmental Options wasn’t one in every of them. The ten shares that made the lower may produce monster returns within the coming years.
Contemplate when Netflix made this checklist on December 17, 2004… if you happen to invested $1,000 on the time of our suggestion, you’d have $471,827!* Or when Nvidia made this checklist on April 15, 2005… if you happen to invested $1,000 on the time of our suggestion, you’d have $1,319,291!*
Now, it’s value noting Inventory Advisor’s complete common return is 986% — a market-crushing outperformance in comparison with 207% for the S&P 500. Do not miss the most recent prime 10 checklist, out there with Inventory Advisor, and be part of an investing group constructed by particular person traders for particular person traders.
*Inventory Advisor returns as of Might 9, 2026.
This text is a transcript of this convention name produced for The Motley Idiot. Whereas we try for our Silly Greatest, there could also be errors, omissions, or inaccuracies on this transcript. As with all our articles, The Motley Idiot doesn’t assume any accountability in your use of this content material, and we strongly encourage you to do your individual analysis, together with listening to the decision your self and studying the corporate’s SEC filings. Please see our Terms and Conditions for added particulars, together with our Compulsory Capitalized Disclaimers of Legal responsibility.
The Motley Idiot has no place in any of the shares talked about. The Motley Idiot has a disclosure policy.
Tomi (TOMZ) Q4 2025 Earnings Transcript was initially printed by The Motley Idiot
